COCRYSTAL PHARMA, INC. Public Float
COCRYSTAL PHARMA, INC. (COCP) had Public Float of $11.60 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $11.60M.
- 2024-06-30: Entity Public Float $18.00M.
- 2023-06-30: Entity Public Float $18.50M.
- 2022-06-30: Entity Public Float $38.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $11.60M 10-K · filed 2026-03-31 |
| 2024-06-30 | $18.00M 10-K · filed 2025-03-31 |
| 2023-06-30 | $18.50M 10-K/A · filed 2024-04-17 |
| 2022-06-30 | $38.00M 10-K · filed 2023-03-29 |
| 2021-06-30 | $116.40M 10-K · filed 2022-03-23 |
| 2020-06-30 | $63.54M 10-K · filed 2021-03-17 |
| 2019-06-28 | $38.56B 10-K · filed 2020-03-27 |
| 2018-06-30 | $53.81B 10-K · filed 2019-04-01 |
| 2017-06-30 | $66.00M 10-K · filed 2018-03-21 |
| 2016-06-30 | $132.00M 10-K · filed 2017-03-31 |
| 2015-06-30 | $177.00M 10-K · filed 2016-03-15 |
| 2014-06-30 | $31.00M 10-K · filed 2015-03-31 |
| 2013-06-30 | $31.00M 10-K · filed 2014-03-31 |
| 2012-06-30 | $205.33M 10-K · filed 2013-04-01 |
| 2011-06-30 | $64.00M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |